// App-Quantinova.ai

OR23-2 : Contrasting Effects of Sitagliptin and Exenatide on Plasma Concentrations of Betatrophin

Researchers

Presenter

  • Husam Ghanim

Principal Investigators

  • Ajay Chaudhuri

  • Antoine Makdissi

  • Sanaa Abuaysheh

  • Kaushik Chatterjee

  • Nitesh D Kuhadiya

  • Manav Batra

  • Paresh Dandona

Medical Centers

  • SUNY Buffalo, Buffalo, NY

  • UB Sch of Med, Williamsville, NY

  • State Univ of NY, Buffalo, NY

  • University of Buffalo, Buffalo, NY

  • State University of New York at Buffalo, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

  • Insulin

Drug/Treatment

  • betatrophin

  • Sitagliptin

  • Exenatide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved